Indivior Pharmaceuticals, Inc. (INDV)
34.49
-0.02
(-0.06%)
USD |
NASDAQ |
Sep 11, 16:00
34.48
-0.01
(-0.03%)
After-Hours: 20:00
Indivior Pharmaceuticals Price : 34.49 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 34.49 | 34.83 | 34.23 | 34.49 | 1.297M |
| Sep 10, 2026 | 34.58 | 34.87 | 34.04 | 34.51 | 1.320M |
| Sep 09, 2026 | 34.32 | 34.80 | 33.92 | 34.77 | 1.352M |
| Sep 08, 2026 | 34.35 | 34.84 | 33.84 | 34.32 | 1.824M |
| Sep 04, 2026 | 34.74 | 35.31 | 34.55 | 34.94 | 1.019M |
| Sep 03, 2026 | 35.18 | 35.23 | 34.57 | 34.83 | 1.826M |
| Sep 02, 2026 | 34.74 | 35.28 | 34.68 | 35.05 | 2.975M |
| Sep 01, 2026 | 35.00 | 35.44 | 34.50 | 34.56 | 2.095M |
| Aug 31, 2026 | 34.87 | 35.30 | 34.33 | 34.93 | 1.963M |
| Aug 28, 2026 | 35.31 | 35.49 | 34.49 | 34.87 | 3.309M |
| Aug 27, 2026 | 35.61 | 35.95 | 35.11 | 35.30 | 1.221M |
| Aug 26, 2026 | 35.90 | 36.20 | 35.55 | 35.82 | 1.275M |
| Aug 25, 2026 | 36.23 | 36.75 | 35.61 | 35.97 | 1.712M |
| Aug 24, 2026 | 36.53 | 36.82 | 35.37 | 36.18 | 1.841M |
| Aug 21, 2026 | 37.68 | 38.52 | 36.70 | 36.87 | 2.497M |
| Aug 20, 2026 | 38.91 | 39.25 | 37.64 | 37.78 | 1.442M |
| Aug 19, 2026 | 39.90 | 40.00 | 38.72 | 39.04 | 2.477M |
| Aug 18, 2026 | 39.48 | 39.92 | 39.08 | 39.43 | 2.339M |
| Aug 17, 2026 | 38.95 | 39.59 | 38.68 | 39.08 | 2.018M |
| Aug 14, 2026 | 38.00 | 39.14 | 37.82 | 39.01 | 988395.0 |
| Aug 13, 2026 | 39.12 | 39.12 | 38.02 | 38.22 | 2.337M |
| Aug 12, 2026 | 38.50 | 39.15 | 37.86 | 38.73 | 2.572M |
| Aug 11, 2026 | 38.82 | 39.29 | 38.39 | 38.43 | 2.213M |
| Aug 10, 2026 | 38.09 | 39.09 | 37.95 | 38.47 | 2.066M |
| Aug 07, 2026 | 38.83 | 38.91 | 38.08 | 38.82 | 1.687M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Supernus Pharmaceuticals, Inc. | 41.64 |
| Liquidia Corp. | 66.74 |
| Corcept Therapeutics, Inc. | 112.79 |
| Collegium Pharmaceutical, Inc. | 22.75 |
| Bristol Myers Squibb Co. | 63.64 |
Price Related Metrics
| PE Ratio | 12.25 |
| PS Ratio | 3.282 |
| PEG Ratio | 0.0532 |
| Earnings Yield | 8.16% |
| Market Cap | 4.070B |
| PEGY Ratio | 0.0532 |
| Operating PE Ratio | 8.217 |
| Normalized PE Ratio | 9.665 |